carbostyril has been researched along with Calcinosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiyoya, M; Daitoku, K; Fukuda, I; Furukawa, K; Kikuchi, H; Motomura, S; Murakami, M; Oshima, Y; Seya, K; Yu, Z | 1 |
| Anderson, E; Bundred, NJ; Clarke, RB; Knox, F; Morris, J; Wärnberg, F; White, D | 1 |
2 other study(ies) available for carbostyril and Calcinosis
| Article | Year |
|---|---|
1-Methyl-2-undecyl-4(1H)-quinolone, a derivative of quinolone alkaloid evocarpine, attenuates high phosphate-induced calcification of human aortic valve interstitial cells by inhibiting phosphate cotransporter PiT-1.
Topics: Aged; Alkaline Phosphatase; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cells, Cultured; Gene Expression; Humans; Middle Aged; Phosphates; Quinolones; Sodium-Phosphate Cotransporter Proteins, Type III | 2016 |
Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Calcinosis; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cell Line, Tumor; Farnesyltranstransferase; Female; Humans; Mammography; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Quinolones; Transplantation, Heterologous | 2006 |